SOLA Biosciences Japan

SOLA Biosciences is a biotechnology company focused on developing innovative therapies using its proprietary TapBoost technology platform. TapBoost is designed to enhance the folding and secretion of specific target proteins, addressing diseases caused by protein deficiency or misfolding. The company's pipeline includes programs for neurodegenerative disorders like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia, as well as genetic conditions like Cystic Fibrosis. By selectively boosting the production of functional proteins, SOLA aims to provide transformative treatments for patients with high unmet medical needs.